Novavax's COVID-flu combo vaccine shows strong immune response in trial
Go back to Novavax's COVID-flu combo vaccine shows strong immune response in trial| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.98 -0.07 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.05 | 52 Week High | $9.23 | |||
| Open | $9.18 | 52 Week Low | $1.16 | |||
| Day High | $9.27 | P/E | N/A | |||
| Day Low | $8.91 | EPS | $-0.30 | |||
| Volume | 1,524,965 | |||||

